Lansforsakringar Fondforvaltning AB (publ)
Position in LLY — ELI LILLY & Co
CIK 2059323
Stockholm, V7
Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$417,402,874
+$126,979,059 QoQ
Shares Held
348,001
+10.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
1.88%
of 13F equity value
Holder Rank
#173
of 4,621 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $1,569,589,305 across 10 Drug Manufacturers - General names. LLY ranks #2 (26.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,523,337 | $478,475,161 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
348,001 | $417,402,874 | |
| 3 | JNJ |
Johnson & Johnson
|
852,974 | $216,629,806 | |
| 4 | ABBV |
AbbVie Inc.
|
583,795 | $146,906,173 | |
| 5 | MRK |
Merck & Co., Inc.
|
830,507 | $106,720,149 | |
| 6 | AMGN |
Amgen Inc
|
164,973 | $59,740,022 | |
| 7 | PFE |
Pfizer Inc
|
2,042,458 | $49,182,388 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
381,309 | $48,174,579 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $417,402,874 | 348,001 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $290,423,815 | 315,757 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $337,208,823 | 313,776 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $237,263,243 | 310,961 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $242,788,516 | 311,455 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $286,115,045 | 346,424 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $270,641,584 | 350,572 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||